Capital World Investors 13D and 13G filings for Gilead Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 11:44 am Sale | 2025-03-31 | 13G | Gilead Sciences, Inc. GILD | Capital World Investors | 53,834,873 4.300% | -29,863,342 (-35.68%) | Filing |
| 2024-02-09 6:21 pm Purchase | 2024-02-07 | 13G | Gilead Sciences, Inc. GILD | Capital World Investors | 83,698,215 6.700% | 14,797,217 (+21.48%) | Filing |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | Gilead Sciences, Inc. GILD | Capital World Investors | 68,900,998 5.500% | 12,538,508 (+22.25%) | Filing |